BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21965100)

  • 1. Acquired von Willebrand syndrome in patients with extracorporeal life support (ECLS).
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Intensive Care Med; 2012 Jan; 38(1):62-8. PubMed ID: 21965100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired Von Willebrand syndrome in patients on long-term support with HeartMate II.
    Heilmann C; Trummer G; Beyersdorf F; Brehm K; Berchtold-Herz M; Schelling J; Geisen U; Zieger B
    Eur J Cardiothorac Surg; 2017 Mar; 51(3):587-590. PubMed ID: 28082469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acquired Von Willebrand syndrome is an early-onset problem in ventricular assist device patients.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Trummer G; Berchtold-Herz M; Schlensak C; Zieger B
    Eur J Cardiothorac Surg; 2011 Dec; 40(6):1328-33; discussion 1233. PubMed ID: 21515067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early diagnosis of acquired von Willebrand Syndrome (AVWS) is elementary for clinical practice in patients treated with ECMO therapy.
    Kalbhenn J; Schmidt R; Nakamura L; Schelling J; Rosenfelder S; Zieger B
    J Atheroscler Thromb; 2015; 22(3):265-71. PubMed ID: 25186021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand syndrome in paediatric patients during mechanical circulatory support.
    Kubicki R; Stiller B; Kroll J; Siepe M; Beyersdorf F; Benk C; Höhn R; Grohmann J; Fleck T; Zieger B
    Eur J Cardiothorac Surg; 2019 Jun; 55(6):1194-1201. PubMed ID: 30590475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired von Willebrand syndrome in patients with ventricular assist device or total artificial heart.
    Heilmann C; Geisen U; Beyersdorf F; Nakamura L; Benk C; Berchtold-Herz M; Trummer G; Schlensak C; Zieger B
    Thromb Haemost; 2010 May; 103(5):962-7. PubMed ID: 20352153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired von Willebrand Syndrome and Desmopressin Resistance During Venovenous Extracorporeal Membrane Oxygenation in Patients With COVID-19: A Prospective Observational Study.
    Kalbhenn J; Glonnegger H; Büchsel M; Priebe HJ; Zieger B
    Crit Care Med; 2022 Aug; 50(8):1246-1255. PubMed ID: 35234414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishing a method for in vitro investigation of mechanical parameters causing acquired von Willebrand syndrome in ventricular assist devices.
    Egger C; Maas J; Hufen T; Schmitz-Rode T; Steinseifer U
    Artif Organs; 2013 Sep; 37(9):833-9. PubMed ID: 23834027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acquired von Willebrand syndrome in congenital heart disease surgery: results from an observational case-series.
    Icheva V; Nowak-Machen M; Budde U; Jaschonek K; Neunhoeffer F; Kumpf M; Hofbeck M; Schlensak C; Wiegand G
    J Thromb Haemost; 2018 Nov; 16(11):2150-2158. PubMed ID: 29908036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic workup of patients with acquired von Willebrand syndrome: a retrospective single-centre cohort study.
    Tiede A; Priesack J; Werwitzke S; Bohlmann K; Oortwijn B; Lenting P; Eisert R; Ganser A; Budde U
    J Thromb Haemost; 2008 Apr; 6(4):569-76. PubMed ID: 18208537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracorporeal membrane oxygenation induces short-term loss of high-molecular-weight von Willebrand factor multimers.
    Tauber H; Ott H; Streif W; Weigel G; Loacker L; Fritz J; Heinz A; Velik-Salchner C
    Anesth Analg; 2015 Apr; 120(4):730-6. PubMed ID: 25565317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of inhibitors in acquired von Willebrand syndrome.
    Mohri H; Motomura S; Kanamori H; Matsuzaki M; Watanabe S; Maruta A; Kodama F; Okubo T
    Blood; 1998 May; 91(10):3623-9. PubMed ID: 9572997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in von Willebrand factor function in type 2A von Willebrand disease and left ventricular assist device-induced acquired von Willebrand syndrome.
    Deconinck S; Tersteeg C; Bailleul E; Delrue L; Vandeputte N; Pareyn I; Itzhar-Baikian N; Deckmyn H; De Meyer SF; Vanderheyden M; Vanhoorelbeke K
    Res Pract Thromb Haemost; 2018 Oct; 2(4):762-766. PubMed ID: 30397685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acquired von Willebrand Syndrome and Platelet Function Defects during Extracorporeal Life Support (Mechanical Circulatory Support).
    Schlagenhauf A; Kalbhenn J; Geisen U; Beyersdorf F; Zieger B
    Hamostaseologie; 2020 Jun; 40(2):221-225. PubMed ID: 32455462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired von Willebrand syndrome in patients with overt hypothyroidism: a prospective cohort study.
    Stuijver DJ; Piantanida E; van Zaane B; Galli L; Romualdi E; Tanda ML; Meijers JC; Büller HR; Gerdes VE; Squizzato A
    Haemophilia; 2014 May; 20(3):326-32. PubMed ID: 24118466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
    Lavin M; Brophy TM; Rawley O; O'Sullivan JM; Hayden PJ; Browne PV; Ryan K; O'Connell N; O'Donnell JS
    J Thromb Haemost; 2016 Jun; 14(6):1200-5. PubMed ID: 26991062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease.
    Geisen U; Heilmann C; Beyersdorf F; Benk C; Berchtold-Herz M; Schlensak C; Budde U; Zieger B
    Eur J Cardiothorac Surg; 2008 Apr; 33(4):679-84. PubMed ID: 18282712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of acquired von Willebrand syndrome after ventricular assist device by total thrombus-formation analysis system.
    Takashio S; Kaikita K; Nishi M; Morioka M; Higo T; Shiose A; Doman T; Horiuchi H; Fukui T; Tsujita K
    ESC Heart Fail; 2020 Oct; 7(5):3235-3239. PubMed ID: 32700467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.